Print This Page

On the Road to Precision Medicine Health Care Leader Series

People, policy and progress toward better and more efficient health care.

inhealth logo

Johns Hopkins Medicine invites you to join the conversation with leading experts about current challenges in precision medicine. This new event series will bring together thought leaders from all sectors to discuss how to improve the way we tailor health care to individuals and create better ways to engage people in the health care system. In this series, our panel of experts will discuss topics such as cost, communication, research and health care delivery.

Upcoming

Launching The Lancet Oncology Commission on Future Cancer Research Priorities in the USA

Hear from top scientists on how they recommend expanding and implementing the Blue Ribbon Panel’s road map for cancer research. They’ll discuss a report that will be published by the journal The Lancet Oncology and is co-edited by Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, and Chi Van Dang, M.D., Ph.D., scientific director at Ludwig Cancer Research and professor at The Wistar Institute. Learn what you need to know about investing in research, prevention and treatment of cancer, the second leading cause of death in the U.S. Reserve your attendance now by emailing JHontheRoad@jhmi.edu.  

Wednesday, November 1, from 8:30 a.m. to 12:00 p.m.
Capitol Hill Hart Senate Office Building, Room 902
120 Constitution Avenue NE, Washington, D.C. 20002

RSVP via e-mail by October 25 

Past Events

Lower Cost, Better Care

As the cost of health care in the United States continues to rise, of utmost concern are reports that medical bills are creating substantial hardships for patients. Health care debt is now the leading contributor to individual bankruptcy and home foreclosures. Both insured and uninsured patients are burdened by medical bills. And health care quality and safety are compromised as people avoid even the most basic and necessary care because of cost. Health care providers are in a unique position to lead the transition to value-based care. Medical providers and professional societies across the country are working to reduce use of unnecessary tests, procedures and treatments that increase patients’ financial burdens without adding value to their care. 

Wednesday, September. 27, from 9 to 10:30 a.m.
Senate Visitors Center, Room 201-00
Washington, D.C. 20045

Moderator

 

Paul Rothman
Dean of the Medical Faculty
CEO of Johns Hopkins Medicine

Panelists

Michael Kanter
Executive Vice President of Quality and Chief Quality Officer, The Permanente Federation
Medical Director, Quality and Clinical Analysis, Southern California Permanente Medical Group

Curt Medeiros
President, Optum Life Sciences at UnitedHealth Group

Peter Pronovost
Senior VP for Patient Safety and Quality, Johns Hopkins Medicine
Director, Armstrong Institute for Patient Safety and Quality
@PeterPronovost

Lisa Simpson
President and CEO, AcademyHealth
@DrSimpsonHSR

Follow the discussion on @HopkinsinHealth and #HopkinsOntheRoad.

Immunotherapy: Precision Medicine in Action

One of the most recent examples of individualized or precision medicine is cancer immunotherapy. This approach of making cancer cells visible to the patient’s own immune system, allowing it to take action against cancer, has led to numerous success stories for those with various cancers. What do leaders predict for the future of immunotherapy? How are academia and drug companies working together to move this field forward? Learn more from a panel of health care industry leaders, including those from the Bloomberg~Kimmel Institute for Cancer Immunotherapy, patient advocacy groups and the pharmaceutical industry.

Wednesday, March 8, from 9 to 10:30 a.m.
National Press Club
529 14th St. NW, 13th Floor, Fourth Estate Room, Washington, DC 20045
Registration is free.
Please RSVP via email.

Johns Hopkins inHealth: On the Road to Precision Medicine

Johns Hopkins inHealth kicks off the Hopkins On The Road health care leader series, where experts discuss the importance of precision medicine within the field of immunotherapy.

Moderator

 

Laurie McGingley
Health and medical reporter, The Washington Post
@lauriemcginley2

Panelists

Margaret Anderson
Executive Director, FasterCures

Roy Baynes, MD, PhD
Senior Vice President and Head, Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Glenn Dranoff, MD
Global Head of Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research

Elizabeth Jaffee, MD
The Dana and Albert "Cubby" Broccoli Professor of Oncology
Deputy Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Co-Director, Skip Viragh Center for Pancreas Cancer
Associate Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
Co-Chair, Blue Ribbon Panel, Vice President Joe Biden’s Cancer Moonshot Initiative

William Nelson, MD, PhD
Marion I. Knott Director and Professor of Oncology and Director of The Sidney Kimmel Comprehensive Cancer Center
@HopkinsinHealth